HSCS News & Events

HeartSciences announced that the European Patent Office has granted the company a patent titled "Electrocardiogram-Based Assessment of Diastolic Function." The patent covers machine-learning models and methods designed to calculate quantitative estimates of echocardiogram parameters indicative of diastolic function using electrocardiogram data. The patent provides coverage across 19 European countries, expanding HeartSciences' intellectual property portfolio to more than 45 granted patents.

HeartSciences announced that it has entered into a commercial agreement with North Shore Health, a community hospital serving Cook County, Minnesota and the surrounding region, to deploy the MyoVista Insights platform. North Shore Health is part of the Cibolo Rural Health Networks network, which previously selected MyoVista Insights as its endorsed ECG management platform for hospitals within its high-value networks. The agreement represents another SaaS-based revenue deployment for HeartSciences and further supports the company's commercial rollout of MyoVista Insights. The cloud-native, device-agnostic platform is designed to improve workflow efficiency, support enterprise-grade EHR interoperability, and create a scalable foundation for the use of cleared AI-ECG algorithms within routine clinical workflows.

HeartSciences announced that it has signed a commercial agreement with St. Vincent Health to deploy the MyoVista Insights platform.

HeartSciences announced that the University of the West of England, UWE, has adopted the Company's MyoVista Insights platform and MyoVista wavECG device as its exclusive ECG technologies to establish a Reference Center for ECG Education and Technology. Under the agreement, MyoVista Insights and the MyoVista wavECG device will be used exclusively across UWE's cardiac and physiological science teaching programs to train the next generation of cardiac scientists.